EYPT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.74%

Insider Buying (Last 12 Months): $89,515,138.62

Insider Selling (Last 12 Months): $45,265,564.57

EyePoint Pharmaceuticals Insider Trading History Chart

EyePoint Pharmaceuticals Share Price & Price History

^$8.96

▼ -0.26 (-2.82%)

As of 11/20/2024 01:00 AM ET

Days: 30 | 90 | 365

“This Changes Everything” - Trump Hands Millions Massive IRS Gift

From Colonial Metals | Ad

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!

EyePoint Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/20/2024	Wendy F Dicicco	Director	Buy	2,567	$7.79	$19,996.93	9,967
7/12/2024	David R Guyer	Director	Sell	11,625	$10.06	$116,947.50	1,850
5/14/2024	David R Guyer	Director	Sell	11,625	$12.65	$147,056.25	5,550
5/6/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	850,000	$11.86	$10,081,000.00	8,325,000
4/18/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	581,765	$18.03	$10,489,222.95	7,475,000
2/2/2024	David Scott Jones	SVP	Sell	209	$28.49	$5,954.41	37,962
1/26/2024	Dario A Paggiarino	Insider	Sell	49,325	$25.66	$1,265,679.50	36,505
1/25/2024	David Scott Jones	SVP	Sell	600	$25.00	$15,000.00	37,962
1/23/2024	Dario A Paggiarino	Insider	Sell	5,135	$25.00	$128,375.00	36,505
1/23/2024	David Scott Jones	SVP	Sell	900	$25.00	$22,500.00	37,962
1/11/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	750,000	$19.75	$14,812,500.00	6,893,235
1/11/2024	Ye Liu	Director	Sell	1,910,500	$19.45	$37,159,225.00	100,221
1/9/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	105,000	$21.32	$2,238,600.00	6,143,235
1/8/2024	Dario A Paggiarino	Insider	Sell	22,913	$21.13	$484,151.69	36,505
12/13/2023	Dario A Paggiarino	Insider	Sell	1,458	$20.00	$29,160.00	25,707
12/8/2023	Cormorant Asset Management, Lp	Major Shareholder	Buy	588,235	$17.00	$9,999,995.00	6,038,235
12/6/2023	Ye Liu	Director	Sell	266,242	$18.41	$4,901,515.22	2,010,721
12/4/2023	Cormorant Asset Management, Lp	Major Shareholder	Buy	1,919,057	$21.82	$41,873,823.74	5,450,000
12/4/2023	Michael Craig Pine	Insider	Sell	45,000	$22.00	$990,000.00	5,343
9/1/2023	Ew Healthcare Partners, L.P.	Major Shareholder	Sell	20,000	$9.90	$198,000.00	3,490,921
8/30/2023	Ew Healthcare Partners, L.P.	Major Shareholder	Sell	60,976	$10.92	$665,857.92	3,589,416
8/28/2023	Ew Healthcare Partners, L.P.	Major Shareholder	Sell	60,858	$11.71	$712,647.18	3,738,246
8/24/2023	Ew Healthcare Partners, L.P.	Major Shareholder	Sell	139,280	$14.62	$2,036,273.60	3,883,760
8/22/2023	Ew Healthcare Partners, L.P.	Major Shareholder	Sell	46,778	$14.62	$683,894.36	4,144,143
5/30/2023	Ye Liu	Director	Sell	1	$6.00	$6.00	3,010,721

This Bull Market Indicator called NVDA at $116

From WealthPress | Ad

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

SEC Filings (Institutional Ownership Changes) for EyePoint Pharmaceuticals (NASDAQ:EYPT)

99.41% of EyePoint Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

EyePoint Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	1,199,056	$9.58M	0.0%	+16.1%	2.240%
11/15/2024	Barclays PLC	245,045	$1.96M	0.0%	+410.4%	0.359%
11/15/2024	Jane Street Group LLC	42,586	$0.34M	0.0%	-46.9%	0.080%
11/15/2024	Wellington Management Group LLP	171,764	$1.37M	0.0%	+59.4%	0.321%
11/15/2024	State Street Corp	1,215,881	$9.72M	0.0%	-0.3%	2.272%
11/15/2024	Point72 Asset Management L.P.	451,318	$3.61M	0.0%	-28.4%	0.843%
11/15/2024	Patient Square Capital LP	1,361,979	$10.88M	4.0%	N/A	2.545%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	68,630	$0.55M	0.0%	-13.4%	0.128%
11/13/2024	Dynamic Technology Lab Private Ltd	12,049	$96K	0.0%	-77.3%	0.023%
11/12/2024	Charles Schwab Investment Management Inc.	142,763	$1.14M	0.0%	+5.9%	0.267%
11/9/2024	Intech Investment Management LLC	16,968	$0.14M	0.0%	N/A	0.032%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	48,791	$0.39M	0.0%	-59.5%	0.091%
11/5/2024	GSA Capital Partners LLP	32,979	$0.26M	0.0%	+129.6%	0.062%
10/29/2024	Greenwich Wealth Management LLC	11,700	$93K	0.0%	+8.3%	0.022%
10/25/2024	China Universal Asset Management Co. Ltd.	10,293	$82K	0.0%	+68.2%	0.019%
10/19/2024	Cyndeo Wealth Partners LLC	12,540	$100K	0.0%	N/A	0.023%
10/11/2024	Woodstock Corp	71,480	$0.57M	0.1%	+29.1%	0.134%
10/10/2024	Essex Investment Management Co. LLC	142,144	$1.14M	0.2%	+234.2%	0.273%
10/3/2024	SG Americas Securities LLC	19,303	$0.15M	0.0%	-74.7%	0.036%
9/16/2024	Point72 DIFC Ltd	3,962	$34K	0.0%	-23.8%	0.007%
8/19/2024	Fiera Capital Corp	677,038	$5.89M	0.0%	+0.9%	1.300%
8/19/2024	Point72 Asset Management L.P.	630,769	$5.49M	0.0%	N/A	1.211%
8/16/2024	Perceptive Advisors LLC	640,274	$5.57M	0.1%	+8.6%	1.229%
8/15/2024	The Manufacturers Life Insurance Company	68,043	$0.59M	0.0%	-11.1%	0.131%
8/15/2024	Millennium Management LLC	580,716	$5.05M	0.0%	-71.6%	1.115%
8/15/2024	Deerfield Management Company L.P. Series C	877,790	$7.64M	0.1%	+51.4%	1.685%
8/15/2024	AQR Capital Management LLC	28,723	$0.25M	0.0%	-51.4%	0.054%
8/14/2024	Squarepoint Ops LLC	46,456	$0.40M	0.0%	-66.5%	0.087%
8/14/2024	Cubist Systematic Strategies LLC	476,250	$4.14M	0.0%	+842.5%	0.890%
8/14/2024	Profund Advisors LLC	12,793	$0.11M	0.0%	-16.6%	0.025%
8/13/2024	Canada Pension Plan Investment Board	15,600	$0.14M	0.0%	-88.0%	0.030%
8/9/2024	Renaissance Technologies LLC	152,800	$1.33M	0.0%	+112.5%	0.293%
8/9/2024	Dimensional Fund Advisors LP	28,447	$0.25M	0.0%	-3.9%	0.055%
8/9/2024	Greenwich Wealth Management LLC	10,800	$94K	0.0%	N/A	0.021%
8/8/2024	Federated Hermes Inc.	290,212	$2.53M	0.0%	-54.9%	0.557%
8/6/2024	Quest Partners LLC	8,905	$77K	0.0%	-66.9%	0.017%
8/5/2024	Arizona State Retirement System	13,251	$0.12M	0.0%	+9.7%	0.025%
8/3/2024	TD Asset Management Inc	127,694	$1.11M	0.0%	-10.6%	0.245%
8/1/2024	Fiera Capital Corp	677,038	$5.89M	0.0%	+0.9%	1.300%
8/1/2024	Rhumbline Advisers	76,833	$0.67M	0.0%	+32.6%	0.148%
7/29/2024	Panagora Asset Management Inc.	120,721	$1.05M	0.0%	+205.5%	0.232%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	10,888	$95K	0.0%	+271.0%	0.021%
7/26/2024	Legato Capital Management LLC	19,437	$0.17M	0.0%	-72.9%	0.037%
7/26/2024	Bank of New York Mellon Corp	204,892	$1.78M	0.0%	+32.6%	0.393%
7/12/2024	SG Americas Securities LLC	76,288	$0.66M	0.0%	N/A	0.146%
7/8/2024	Woodstock Corp	55,387	$0.48M	0.0%	+80.0%	0.106%
5/20/2024	Virtu Financial LLC	11,639	$0.24M	0.0%	N/A	0.022%
5/17/2024	RA Capital Management L.P.	938,591	$19.40M	0.2%	N/A	1.802%
5/16/2024	California State Teachers Retirement System	43,275	$0.89M	0.0%	+884.2%	0.083%
5/16/2024	Janus Henderson Group PLC	26,856	$0.56M	0.0%	N/A	0.052%
5/15/2024	Price T Rowe Associates Inc. MD	2,465,815	$50.97M	0.0%	-2.3%	4.735%
5/14/2024	American International Group Inc.	18,378	$0.38M	0.0%	+38.4%	0.035%
5/13/2024	Ameritas Investment Partners Inc.	3,719	$77K	0.0%	+44.0%	0.007%
5/10/2024	Vanguard Group Inc.	2,396,228	$49.53M	0.0%	+17.8%	4.601%
5/9/2024	Lord Abbett & CO. LLC	242,580	$5.02M	0.0%	-34.6%	0.466%
5/8/2024	Entropy Technologies LP	13,512	$0.28M	0.0%	N/A	0.026%
5/8/2024	ProShare Advisors LLC	10,121	$0.21M	0.0%	N/A	0.019%
5/8/2024	Legacy Capital Group California Inc.	33,832	$0.70M	0.3%	N/A	0.065%
5/7/2024	Swiss National Bank	86,700	$1.79M	0.0%	N/A	0.166%
5/3/2024	Essex Investment Management Co. LLC	149,819	$3.10M	0.6%	+1.5%	0.288%
5/1/2024	Capstone Investment Advisors LLC	11,130	$0.23M	0.0%	N/A	0.021%
5/1/2024	Janney Montgomery Scott LLC	18,040	$0.37M	0.0%	+26.5%	0.035%
4/29/2024	China Universal Asset Management Co. Ltd.	9,393	$0.19M	0.0%	+129.9%	0.018%
4/9/2024	Woodstock Corp	30,778	$0.64M	0.1%	+38.3%	0.062%
3/21/2024	Healthcare of Ontario Pension Plan Trust Fund	137,000	$3.17M	0.0%	N/A	0.275%
2/22/2024	Sierra Summit Advisors LLC	22,613	$0.52M	0.2%	N/A	0.048%
2/20/2024	Quarry LP	3,000	$69K	0.0%	-75.0%	0.006%
2/15/2024	PFM Health Sciences LP	170,871	$3.95M	0.2%	N/A	0.363%
2/14/2024	Artia Global Partners LP	50,000	$1.16M	0.3%	N/A	0.106%
2/14/2024	Ghisallo Capital Management LLC	108,634	$2.51M	0.3%	N/A	0.231%
2/14/2024	Sectoral Asset Management Inc.	81,160	$1.88M	0.8%	-53.9%	0.172%
2/14/2024	Ratan Capital Management LP	45,000	$1.04M	0.7%	N/A	0.096%
2/13/2024	Tower Research Capital LLC TRC	4,724	$0.11M	0.0%	+36.0%	0.010%
2/13/2024	Bard Associates Inc.	14,600	$0.34M	0.1%	-23.6%	0.031%
2/12/2024	Scotia Capital Inc.	8,963	$0.21M	0.0%	-90.1%	0.019%
2/12/2024	Monashee Investment Management LLC	175,000	$4.04M	0.7%	N/A	0.372%
2/12/2024	TD Asset Management Inc	142,894	$3.30M	0.0%	+99.0%	0.304%
2/9/2024	Franklin Resources Inc.	4,640,651	$107.25M	0.1%	+11.8%	9.859%
2/9/2024	Trexquant Investment LP	48,760	$1.13M	0.0%	-53.4%	0.104%
2/9/2024	UBS Group AG	574,169	$13.27M	0.0%	+9.0%	1.220%
2/8/2024	Panagora Asset Management Inc.	80,780	$1.87M	0.0%	+7.4%	0.172%
2/8/2024	Nicholas Investment Partners LP	53,236	$1.23M	0.1%	N/A	0.113%
2/8/2024	First Turn Management LLC	317,010	$7.33M	1.1%	N/A	0.673%
2/8/2024	Essex Investment Management Co. LLC	147,541	$3.41M	0.7%	-28.8%	0.313%
2/7/2024	Jump Financial LLC	23,794	$0.55M	0.0%	-51.4%	0.051%
2/5/2024	Victory Capital Management Inc.	28,530	$0.66M	0.0%	N/A	0.061%
2/1/2024	New York State Common Retirement Fund	21,511	$0.50M	0.0%	+176.6%	0.046%
2/1/2024	Jennison Associates LLC	1,066,240	$24.64M	0.0%	N/A	2.265%
1/31/2024	Federated Hermes Inc.	674,824	$15.60M	0.0%	+194.0%	1.434%
1/30/2024	Strs Ohio	23,300	$0.54M	0.0%	-5.3%	0.050%
1/26/2024	Toth Financial Advisory Corp	5,000	$0.12M	0.0%	+42.9%	0.011%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	15,584	$0.36M	0.0%	+6.0%	0.033%
1/24/2024	DekaBank Deutsche Girozentrale	35,000	$0.82M	0.0%	N/A	0.074%
1/24/2024	China Universal Asset Management Co. Ltd.	4,085	$94K	0.0%	N/A	0.009%
1/16/2024	Legato Capital Management LLC	59,347	$1.37M	0.2%	-23.3%	0.126%
1/12/2024	FNY Investment Advisers LLC	1,210	$27K	0.0%	N/A	0.003%
1/8/2024	Woodstock Corp	22,253	$0.51M	0.1%	N/A	0.047%
1/1/2024	Deutsche Bank AG	21,764	$0.17M	0.0%	+4.0%	0.046%
11/22/2023	Graham Capital Management L.P.	30,042	$0.24M	0.0%	N/A	0.085%
11/15/2023	Scotia Capital Inc.	90,963	$0.73M	0.0%	+144.9%	0.258%

Data available starting January 2016

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $8.96

$8.70

$9.16

50 Day Range

MA: $9.78

$7.98

$12.12

52 Week Range

Now: $8.96

$5.86

$30.99

Volume

1,405,014 shs

Average Volume

940,017 shs

Market Capitalization

$611.19 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.5

Who are the company insiders with the largest holdings of EyePoint Pharmaceuticals?: EyePoint Pharmaceuticals' top insider investors include:
Cormorant Asset Management, Lp (Major Shareholder)
Ew Healthcare Partners, LP (Major Shareholder)
Ye Liu (Director)
David Scott Jones (SVP)
Dario A Paggiarino (Insider)
Wendy F Dicicco (Director)
David R Guyer (Director)
Michael Craig Pine (Insider)
Learn More about top insider investors at EyePoint Pharmaceuticals.
Who are the major institutional investors of EyePoint Pharmaceuticals?: EyePoint Pharmaceuticals' top institutional shareholders include:
Patient Square Capital LP — 2.54%
State Street Corp — 2.27%
Geode Capital Management LLC — 2.24%
Point72 Asset Management L.P. — 0.84%
Barclays PLC — 0.36%
Wellington Management Group LLP — 0.32%
Learn More about top institutional investors of EyePoint Pharmaceuticals stock.
Which major investors are selling EyePoint Pharmaceuticals stock?: Within the last quarter, EYPT stock was sold by these institutional investors:
Point72 Asset Management L.P.
Connor Clark & Lunn Investment Management Ltd.
SG Americas Securities LLC
Dynamic Technology Lab Private Ltd
Jane Street Group LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
State Street Corp
During the previous year, company insiders that have sold EyePoint Pharmaceuticals company stock include:
Cormorant Asset Management, Lp (Major Shareholder)
Ew Healthcare Partners, LP (Major Shareholder)
Ye Liu (Director)
David Scott Jones (SVP)
Dario A Paggiarino (Insider)
Learn More investors selling EyePoint Pharmaceuticals stock.
Which major investors are buying EyePoint Pharmaceuticals stock?: Within the last quarter, EYPT stock was purchased by institutional investors including:
Patient Square Capital LP
Barclays PLC
Geode Capital Management LLC
Essex Investment Management Co. LLC
Wellington Management Group LLP
Wolverine Trading LLC
GSA Capital Partners LLP
Intech Investment Management LLC
During the previous year, these company insiders have bought EyePoint Pharmaceuticals stock:
Cormorant Asset Management, Lp (Major Shareholder)
Ew Healthcare Partners, LP (Major Shareholder)
Learn More investors buying EyePoint Pharmaceuticals stock.